In Jharkhand, Two People Including A Quack Died After Consuming TB Medicine Made From Herbs

GUMLA:  Two individuals, including a quack, lost their lives, and two others fell ill after consuming medicine prepared by the quack on Friday night.

A resident of Silafari village, Sujit Tirkey, approached Sudhir Tirkey of Madaikona village in Chainpur for medicines to relieve him of some ailment. The quack took Sujit to the house of one Basant Tirkey.

Basant’s wife, Sushma Tirkey, said, “I ground two herbs and boiled it in ghee. Then, Sudhir mixed it with honey and turned these into pills. He consumed one while assuring us that the medicine could be taken by anyone for strength.

However, all began vomiting and complained of headache soon after. Sudhir, Basant, Sujit, and a daily wager, Saddam, were taken to the community health centre, Chainpur, from where they were referred to the Sadar Hospital.”

Civil surgeon Dr Nawal Kumar said, “Sudhir and Basant died on the way while Sujit and Saddam were admitted to a local hospital.”

Related Posts

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform